Identifying a therapeutic target for vancomycin against staphylococci in young infants.
Amanda GweeStephen B DuffullAndrew J DaleyMichelle LimSusie GermanoHajira BilalSamantha HallNigel CurtisXiao ZhuPublished in: The Journal of antimicrobial chemotherapy (2022)
An AUC0-24 ≥300 mg/L·h or AUC24-48 ≥424 mg/L·h was associated with an increase in bacteriological cure in young infants with staphylococcal bloodstream infections.